The Role of Traditional Chinese Medicine and Chinese Pharmacopoeia in the Evaluation and Treatment of COVID-19


Cite item

Full Text

Abstract

The epidemic prompted by COVID-19 continues to spread, causing a great risk to the general population's safety and health. There are still no drugs capable of curing it. Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) are the two other diseases caused by coronaviruses. Traditional Chinese Medicine (TCM) showed benefits in treating SARS and MERS by preventing the disease early, substantially mitigating symptoms, shortening the treatment period, and minimizing risks and adverse reactions caused by hormone therapy. Although several vaccines have been developed and are being used for the treatment of COVID-19, existing vaccines cannot provide complete protection against the virus due to the rapid evolution and mutation of the virus, as mutated viral epitopes evade the vaccine’s target and decrease the efficacy of vaccines. Thus, there is a need to develop alternative options. TCM has demonstrated positive effects in the treatment of COVID-19. Previous research studies on TCM showed broad-spectrum antiviral activity, offering a range of possibilities for their potential use against COVID-19. This study shed some light on common TCM used for SARS and MERS outbreaks and their effective use for COVID-19 management. This study provides new insights into COVID-19 drug discovery.

About the authors

Amin Gasmi

, Société Francophone de Nutrithérapie et de Nutrigénétique Appliquée

Email: info@benthamscience.net

Sadaf Noor

Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University

Email: info@benthamscience.net

Maryam Dadar

, CONEM Iran Microbiology Research Group

Email: info@benthamscience.net

Yuliya Semenova

School of Medicine, Nazarbayev University

Email: info@benthamscience.net

Alain Menzel

, Laboratoires Réunis

Email: info@benthamscience.net

Asma Gasmi Benahmed

, Académie Internationale de Médecine Dentaire Intégrative

Email: info@benthamscience.net

Geir Bjørklund

, Council for Nutritional and Environmental Medicine (CONEM)

Author for correspondence.
Email: info@benthamscience.net

References

  1. Zu ZY, Jiang MD, Xu PP, et al. Coronavirus disease 2019 (COVID-19): A perspective from China. Radiology 2020; 296(2): E15-25. doi: 10.1148/radiol.2020200490 PMID: 32083985
  2. Dhama K, Sharun K, Tiwari R, et al. COVID-19, an emerging coronavirus infection: Advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. Hum Vaccin Immunother 2020; 16(6): 1232-8. doi: 10.1080/21645515.2020.1735227 PMID: 32186952
  3. Gasmi A, Srinath S, Dadar M, et al. A global survey in the developmental landscape of possible vaccination strategies for COVID-19. Clin Immunol 2022; 237: 108958. doi: 10.1016/j.clim.2022.108958 PMID: 35218966
  4. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382(8): 727-33. doi: 10.1056/NEJMoa2001017 PMID: 31978945
  5. Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature 2020; 579(7798): 265-9. doi: 10.1038/s41586-020-2008-3 PMID: 32015508
  6. Gokseven Y, Ozturk GZ, Karadeniz E, Sarı E, Tas BG , Ozdemir HM. The fear of COVID-19 infection in older people. J Geriatr Psychiatry Neurol 2022; 35(3): 460-6. doi: 10.1177/08919887211002651 PMID: 33745357
  7. Honarmand A, Sheybani F, Aflatoonian E, Saberinia A. COVID-19 patients at referral to hospital during the first peak of disease: Common clinical findings including myalgia and fatigue. Eur J Transl Myol 2022; 32(3): 10731. doi: 10.4081/ejtm.2022.10731 PMID: 36036352
  8. Zhou P, Yang X-L, Wang X-G, et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. BioRxiv 2020. doi: 10.1101/2020.01.22.914952
  9. Tian S, Hu N, Lou J, et al. Characteristics of COVID-19 infection in Beijing. J Infect 2020; 80(4): 401-6. doi: 10.1016/j.jinf.2020.02.018 PMID: 32112886
  10. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020; 382(13): 1199-207. doi: 10.1056/NEJMoa2001316 PMID: 31995857
  11. Zhou Y, Fan L, Xie DH, et al. A network pharmacology approach to explore the mechanism of action of Yiqi Fumai lyophilized injection in the treatment of novel coronavirus disease. Trad Med Res 2023; 8(3): 13. doi: 10.53388/TMR20220411002
  12. John Hopkins University Medicine. Coronavirus resource centre. COVID-19 dashboard. Available from: https://coronavirus.jhu.edu/map.html (Accessed on: January 6, 2024).
  13. Semenova Y, Trenina V, Pivina L, et al. The lessons of COVID-19, SARS, and MERS: Implications for preventive strategies. Int J Healthc Manag 2022; 15(4): 314-24. doi: 10.1080/20479700.2022.2051126
  14. Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): A review. JAMA 2020; 323(18): 1824-36. doi: 10.1001/jama.2020.6019 PMID: 32282022
  15. Wilder-Smith A, Chiew CJ, Lee VJ. Can we contain the COVID-19 outbreak with the same measures as for SARS? Lancet Infect Dis 2020; 20(5): e102-7. doi: 10.1016/S1473-3099(20)30129-8 PMID: 32145768
  16. Zhong N. Management and prevention of SARS in China. Philos Trans R Soc Lond B Biol Sci 2004; 359(1447): 1115-6. doi: 10.1098/rstb.2004.1491 PMID: 15306397
  17. Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003; 348(20): 1953-66. doi: 10.1056/NEJMoa030781 PMID: 12690092
  18. Lau SKP, Woo PCY, Li KSM, et al. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc Natl Acad Sci 2005; 102(39): 14040-5. doi: 10.1073/pnas.0506735102 PMID: 16169905
  19. Chen Y, Guo JJ, Healy DP, Zhan S. Effect of integrated traditional Chinese medicine and Western medicine on the treatment of severe acute respiratory syndrome: A meta-analysis. Pharm Pract 2007; 5(1): 1-9. doi: 10.4321/S1886-36552007000100001 PMID: 25214911
  20. Wen CC, Shyur LF, Jan JT, et al. Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication. J Tradit Complement Med 2011; 1(1): 41-50. doi: 10.1016/S2225-4110(16)30055-4 PMID: 24716104
  21. Zhang MM, Liu X-M, He L. Effect of integrated traditional Chinese and Western medicine on SARS: A review of clinical evidence. World J Gastroenterol 2004; 10(23): 3500-5. doi: 10.3748/wjg.v10.i23.3500 PMID: 15526373
  22. Chen Z, Nakamura T. Statistical evidence for the usefulness of Chinese medicine in the treatment of SARS. Phytother Res 2004; 18(7): 592-4. doi: 10.1002/ptr.1485 PMID: 15305324
  23. Lau TF, Leung PC, Wong ELY, et al. Using herbal medicine as a means of prevention experience during the SARS crisis. Am J Chin Med 2005; 33(3): 345-56. doi: 10.1142/S0192415X05002965 PMID: 16047553
  24. Poon PMK, Wong CK, Fung KP, et al. Immunomodulatory effects of a traditional Chinese medicine with potential antiviral activity: A self-control study. Am J Chin Med 2006; 34(1): 13-21. doi: 10.1142/S0192415X0600359X PMID: 16437735
  25. Gachelin G, Garner P, Ferroni E, Tröhler U, Chalmers I. Evaluating Cinchona bark and quinine for treating and preventing malaria. J R Soc Med 2017; 110(1): 31-40. doi: 10.1177/0141076816681421 PMID: 28106483
  26. Kuttithodi AM, Narayanankutty A, Visakh NU, et al. Chemical composition of the Cinnamomum malabatrum leaf essential oil and analysis of its antioxidant, enzyme inhibitory and antibacterial activities. Antibiotics 2023; 12(5): 940. doi: 10.3390/antibiotics12050940 PMID: 37237843
  27. Narayanankutty A, Visakh NU, Sasidharan A, et al. Chemical composition, antioxidant, anti-bacterial, and anti-cancer activities of essential oils extracted from Citrus limetta risso peel waste remains after commercial use. Molecules 2022; 27(23): 8329. doi: 10.3390/molecules27238329 PMID: 36500421
  28. Rastija V, Vrandečić K, , Ćosić J , et al. Antifungal activities of fluorinated pyrazole aldehydes on phytopathogenic fungi, and their effect on entomopathogenic nematodes, and soil-beneficial bacteria. Int J Mol Sci 2023; 24(11): 9335. doi: 10.3390/ijms24119335 PMID: 37298285
  29. Narayanankutty A, Kunnath K, Alfarhan A, Rajagopal R, Ramesh V. Chemical composition of Cinnamomum verum leaf and flower essential oils and analysis of their antibacterial, insecticidal, and larvicidal properties. Molecules 2021; 26(20): 6303. doi: 10.3390/molecules26206303 PMID: 34684884
  30. Di Sotto A, Vitalone A, Giacomo DS. Plant-derived nutraceuticals and immune system modulation: An evidence-based overview. Vaccines 2020; 8(3): 468. doi: 10.3390/vaccines8030468 PMID: 32842641
  31. Ashique S, Sandhu NK. "Ayurvedic System": A new possible safe and effective way to get rid of this critical COVID-19 pandemic situation-A review. Curr Tradit Med 2022; 8(1): e130421192818. doi: 10.2174/2215083807666210413113113
  32. Girija PLT, Sivan N. Ayurvedic treatment of COVID-19: A case report. J Ayurveda Integr Med 2022; 13(1): 100329. doi: 10.1016/j.jaim.2020.06.001 PMID: 32680602
  33. Huang K, Zhang P, Zhang Z, et al. Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms. Pharmacol Ther 2021; 225: 107843. doi: 10.1016/j.pharmthera.2021.107843 PMID: 33811957
  34. Kuchta K, Cameron S, Lee M, Cai SQ, Shoyama Y. Which East Asian herbal medicines can decrease viral infections? Phytochem Rev 2022; 21(1): 219-37. doi: 10.1007/s11101-021-09756-2 PMID: 34466134
  35. Masui S, Nabeshima S, Ajisaka K, et al. Maoto, a traditional Japanese herbal medicine, inhibits uncoating of influenza virus. Evid Based Complement Alternat Med 2017; 2017: 1-12. doi: 10.1155/2017/1062065 PMID: 28904550
  36. Wolkerstorfer A, Kurz H, Bachhofner N, Szolar OHJ. Glycyrrhizin inhibits influenza A virus uptake into the cell. Antiviral Res 2009; 83(2): 171-8. doi: 10.1016/j.antiviral.2009.04.012 PMID: 19416738
  37. Huan C, Xu Y, Zhang W, Guo T, Pan H, Gao S. Research progress on the antiviral activity of glycyrrhizin and its derivatives in liquorice. Front Pharmacol 2021; 12: 680674. doi: 10.3389/fphar.2021.680674 PMID: 34295250
  38. Wang L, Zhang RM, Liu GY, et al. Chinese herbs in treatment of influenza: A randomized, double-blind, placebo-controlled trial. Respir Med 2010; 104(9): 1362-9. doi: 10.1016/j.rmed.2010.05.015 PMID: 20573492
  39. Ebrahimi E, Jazayeri MSM, Rezaee M-B, Parsania M. Antiviral effects of Aloe vera (L.) Burm. f. and Ruta graveolens L. extract on acyclovir-resistant herpes simplex virus type 1. J Med Plants By-prod 2021; 10(1): 103-8.
  40. Athiban P, Borthakur B, Ganesan S, Swathika B. Evaluation of antimicrobial efficacy of Aloe vera and its effectiveness in decontaminating gutta percha cones. J Conserv Dent 2012; 15(3): 246-8. doi: 10.4103/0972-0707.97949 PMID: 22876011
  41. Alhussani R, Hamad A, Ajeel H. Study of the efficacy of Aloe vera extracts in treatment of non-infected wounds induced by sulferric acid and infected wounds with Staphylococcus aureus. Int J 2015; 3(1): 593-601.
  42. Royani A, Hanafi M, Julistiono H, Manaf A. The total phenolic and flavonoid contents of Aloe vera and Morinda citrifolia extracts as antibacterial material against Pseudomonas aeruginosa. Mater Today Proc 2023; 72: 2796-802. doi: 10.1016/j.matpr.2022.06.466
  43. Feng X, Cao S, Qiu F, Zhang B. Traditional application and modern pharmacological research of Artemisia annua L. Pharmacol Ther 2020; 216: 107650. doi: 10.1016/j.pharmthera.2020.107650 PMID: 32758647
  44. Elfawal MA, Towler MJ, Reich NG, Golenbock D, Weathers PJ, Rich SM. Dried whole plant Artemisia annua as an antimalarial therapy. PLoS One 2012; 7(12): e52746. doi: 10.1371/journal.pone.0052746 PMID: 23289055
  45. Udoh I, Nworu C, Eleazar C, Onyemelukwe F. Antibacterial profile of extracts of Combretum micranthum G. Don against resistant and sensitive nosocomial isolates. J Appl Pharm Sci 2012; 02(04): 142-6.
  46. Halilu M, Yahaya M, Dangoggo S, et al. Isolation and characterization of di-(2-ethylhexyl) phthalate from the leaves of Combretum micranthum (Altum) combretaceae. Int J Sci Glob Sustain 2016; 2(2): 6.
  47. Ross SM. Echinacea purpurea. Holist Nurs Pract 2016; 30(1): 54-7. doi: 10.1097/HNP.0000000000000130 PMID: 26633727
  48. Wijesundara N, Rupasinghe H. Bactericidal and anti-biofilm activity of ethanol extracts derived from selected medicinal plants against Streptococcus pyogenes. Molecules 2019; 24(6): 1165. doi: 10.3390/molecules24061165 PMID: 30909644
  49. Khalaf RF, Mahdi WM. Evaluation of the efficacy of alcoholic extracts of Echinacea purpurea and Aloe vera against methicillin-resistant Staphylococcus aureus isolated from different infections. HIV Nurs 2023; 23(2): 737-43.
  50. Dhama K, Sharun K, Gugjoo MB, et al. A comprehensive review on chemical profile and pharmacological activities of Ocimum basilicum. Food Rev Int 2023; 39(1): 119-47. doi: 10.1080/87559129.2021.1900230
  51. Singh NA, Kumar P. Jyoti, Kumar N. Spices and herbs: Potential antiviral preventives and immunity boosters during COVID-19. Phytother Res 2021; 35(5): 2745-57. doi: 10.1002/ptr.7019 PMID: 33511704
  52. Yucharoen R, Anuchapreeda S, Tragoolpua Y. Anti-herpes simplex virus activity of extracts from the culinary herbs Ocimum sanctum L., Ocimum basilicum L. and Ocimum americanum L. Afr J Biotechnol 2011; 10(5): 860-6.
  53. Kim EH, Kim SW, Park SJ, et al. Greater efficacy of black ginseng (CJ EnerG) over red ginseng against lethal influenza A virus infection. Nutrients 2019; 11(8): 1879. doi: 10.3390/nu11081879 PMID: 31412594
  54. Kim YR, Yang CS. Protective roles of ginseng against bacterial infection. Microb Cell 2018; 5(11): 472-81. doi: 10.15698/mic2018.11.654 PMID: 30483519
  55. Chauhan R, Ruby K, Shori A, Dwivedi J. Solanum nigrum with dynamic therapeutic role: A review. Int J Pharm Sci Rev Res 2012; 15(1): 65-71.
  56. Javed T, Ashfaq UA, Riaz S, Rehman S, Riazuddin S. In-vitro antiviral activity of Solanum nigrum against hepatitis C virus. Virol J 2011; 8(1): 26. doi: 10.1186/1743-422X-8-26 PMID: 21247464
  57. Kekuda TR, Kavya R, Shrungashree RM, Suchitra SV. Screening of selected single and polyherbal ayurvedic medicines for antibacterial and antifungal activity. Anc Sci Life 2010; 29(3): 22-5. PMID: 22557355
  58. Jain A, Garg N. Amalaki: A review on functional and pharmacological properties. J Pharmacogn Phytochem 2016; (3): 4378-82.
  59. Gupta A. Management of Herpes zoster (Visarpa) through ayurvedic approach: A case report. AYU-CaRe 2021; 4(3): 90-4. doi: 10.4103/jacr.jacr_16_21
  60. Perera WPRT, Liyanage JA, Dissanayake KGC, et al. Antiviral potential of selected medicinal herbs and their isolated natural products. BioMed Res Int 2021; 2021: 1-18. doi: 10.1155/2021/7872406 PMID: 34926691
  61. Rizwana H, Al Hazzani AA, Shehata AI, Moubayed NMS. Antibacterial potential of Withania somnifera L. against human pathogenic bacteria. Afr J Microbiol Res 2012; 6(22): 4810-5.
  62. Mehta J, Utkarsh K, Fuloria S, et al. Antibacterial potential of Bacopa monnieri (L.) Wettst. and its bioactive molecules against uropathogens-an in silico study to identify potential lead molecule(s) for the development of new drugs to treat urinary tract infections. Molecules 2022; 27(15): 4971. doi: 10.3390/molecules27154971 PMID: 35956923
  63. Sulochana MK, Kothandan S, Purushothaman I, George SP, Purushothaman SR. Molecular docking and density function theory studies of compounds from Euphorbia hirta and Bacopa monnieri to zika virus structural and nonstructural proteins. Pharmacogn Mag 2018; 14(57): 481-7. doi: 10.4103/pm.pm_89_17
  64. Paul A, Vibhuti A, Raj VS. Evaluation of antiviral activity of Andrographis paniculata and Tinospora cordifolia using in silico and in vitro assay against DENV-2. J Pharmacogn Phytochem 2021; 10(2): 486-96. doi: 10.22271/phyto.2021.v10.i2f.13847
  65. Singh S, Devi P. Pharmacological potential of Tinospora cordifolia (Willd.) Miers ex hook. & Thoms. (Giloy): A review. J Pharmacogn Phytochem 2017; 6(6): 1644-7.
  66. Royani A, Hanafi M, Julistiono H, Dinoto A, Lotulung PDN, Manaf A. The potential of Tinospora cordifolia extracts as antibacterial material against Pseudomonas aeruginosa. Trend Sci 2023; 20(1): 3884. doi: 10.48048/tis.2023.3884
  67. Bag A, Bhattacharyya SK, Pal NK, Chattopadhyay RR. In vitro antimicrobial potential of Terminalia chebula fruit extracts against multidrug-resistant uropathogens. Asian Pac J Trop Biomed 2012; 2(3): S1883-7. doi: 10.1016/S2221-1691(12)60514-0
  68. Kesharwani A, Polachira SK, Nair R, Agarwal A, Mishra NN, Gupta SK. Anti-HSV-2 activity of Terminalia chebula Retz extract and its constituents, chebulagic and chebulinic acids. BMC Complement Altern Med 2017; 17(1): 110. doi: 10.1186/s12906-017-1620-8 PMID: 28196487
  69. Ashrafi S, Rahman M, Ahmed P, Alam S, Hossain MA. Prospective Asian plants with corroborated antiviral potentials: Position standing in recent years. Beni Suef Univ J Basic Appl Sci 2022; 11(1): 47. doi: 10.1186/s43088-022-00218-y PMID: 35402627
  70. Walia S, Singh M. Tracing plants potential effective against dengue virus: A review. Int J Innovat Res Multidisciplinar Field 2021; 7(5): 1-7.
  71. Kaviya M, Balasubramanian B, Bharathi K, et al. Evaluation of nutritional substances and investigation of antioxidant and antimicrobial potentials of Boerhavia diffusa with in silico molecular docking. Molecules 2022; 27(4): 1280. doi: 10.3390/molecules27041280 PMID: 35209067
  72. Prisinda D, Setiawan AS, Fitriadi F. Antibacterial potential of Ocimum sanctum oils in relation to Enterococcus faecalis ATCC 29212. Dent J 2018; 51(3): 104-7. doi: 10.20473/j.djmkg.v51.i3.p104-107
  73. Varshney KK, Varshney M, Nath B. Molecular modeling of isolated phytochemicals from Ocimum sanctum towards exploring potential inhibitors of SARS coronavirus main protease and papain-like protease to treat COVID-19 Available from: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3554371
  74. Parveen R, Shamsi TN, Singh G, Athar T, Fatima S. Phytochemical analysis and in-vitro biochemical characterization of aqueous and methanolic extract of triphala, a conventional herbal remedy. Biotechnol Rep 2018; 17: 126-36. doi: 10.1016/j.btre.2018.02.003 PMID: 29619331
  75. Kumar NS, Nair AS, Nair AM, Murali M. Pharmacological and therapeutic effects of triphala â€"A literature review. J Pharmacogn Phytochem 2016; 5(3): 23-7.
  76. Omran Z, Bader A, Porta A, et al. Evaluation of antimicrobial activity of Triphala constituents and nanoformulation. Evid Based Complement Alternat Med 2020; 2020: 1-11. doi: 10.1155/2020/6976973 PMID: 32831876
  77. Song L, Hu X, Ren X, Liu J, Liu X. Antibacterial modes of herbal flavonoids combat resistant bacteria. Front Pharmacol 2022; 13: 873374. doi: 10.3389/fphar.2022.873374 PMID: 35847042
  78. Li J, Feng S, Liu X, et al. Effects of traditional Chinese medicine and its active ingredients on drug-resistant bacteria. Front Pharmacol 2022; 13: 837907. doi: 10.3389/fphar.2022.837907 PMID: 35721131
  79. Luo C, Ma L, Liu H, et al. Research progress on main symptoms of novel coronavirus pneumonia improved by traditional Chinese medicine. Front Pharmacol 2020; 11: 556885. doi: 10.3389/fphar.2020.556885 PMID: 33013395
  80. Yu C, Yang B. Traditional Chinese Medicine. Springer 2020.
  81. Flower A, Wang LQ, Lewith G, Liu JP, Li Q. Chinese herbal medicine for treating recurrent urinary tract infections in women. Cochrane Libr 2015; 2017(6): CD010446. doi: 10.1002/14651858.CD010446.pub2 PMID: 26040964
  82. Li Y, Zou M, Han Q, Deng L, Weinshilboum RM. Therapeutic potential of triterpenoid saponin anemoside B4 from Pulsatilla chinensis. Pharmacol Res 2020; 160: 105079. doi: 10.1016/j.phrs.2020.105079 PMID: 32679180
  83. Huang S-T, Lai H-C, Lin Y-C, et al. Principles and treatment strategies for the use of Chinese herbal medicine in patients at different stages of coronavirus infection. Am J Cancer Res 2020; 10(7): 2010-31. PMID: 32774998
  84. Jian-Hui L. A handbook of traditional Chinese dermatology. Blue Poppy Enterprises, Inc. 1993.
  85. Xiao Y, Liu Y, Yu K, Ouyang M, Luo R, Zhao X. Chinese herbal medicine Liu Jun Zi Tang and Xiang Sha Liu Jun Zi Tang for functional dyspepsia: Meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med 2012; 2012: 1-7. doi: 10.1155/2012/936459 PMID: 23304226
  86. Fu M, Liu Y, Cheng H, Xu K, Wang G. Coptis chinensis and dried ginger herb combination inhibits gastric tumor growth by interfering with glucose metabolism via LDHA and SLC2A1. J Ethnopharmacol 2022; 284: 114771. doi: 10.1016/j.jep.2021.114771 PMID: 34737010
  87. Borrelli F, Izzo AA. The plant kingdom as a source of anti-ulcer remedies. Phytother Res 2000; 14(8): 581-91. doi: 10.1002/1099-1573(200012)14:83.0.CO;2-S
  88. Chen G, Zhao J, Chen T, et al. Efficacy and safety of Xiaofeng powder (Xiao Feng San) in treating urticaria. Medicine 2018; 97(45): e13039. doi: 10.1097/MD.0000000000013039 PMID: 30407300
  89. Wang L, Wang P, Chen Y, et al. Explore the network pharmacology and molecular docking mechanism of Chaihu Shugan powder with the "Same Treatment for Different Diseases" for insomnia and depression based on the COVID-19 pandemic. 2022. doi: 10.21203/rs.3.rs-1332355/v1
  90. Hackett ES, Twedt DC, Gustafson DL. Milk thistle and its derivative compounds: A review of opportunities for treatment of liver disease. J Vet Intern Med 2013; 27(1): 10-6. doi: 10.1111/jvim.12002 PMID: 23140176
  91. Guo H, Mao J, Qian X, Sun C, Sun H. Varicella-zoster virus prophylaxis with the traditional Chinese medicine Radix isatidis (Banlangen) in patients with multiple myeloma treated with bortezomib. J Altern Complement Med 2011; 17(11): 985-6. doi: 10.1089/acm.2011.0386 PMID: 22087609
  92. Wang K, Coyle ME, Mansu S, Zhang AL, Xue C. Long Dan Xie Gan Tang formula in the management of herpes zoster: A systematic review of randomized controlled trials. J Am Acad Dermatol 2016; 74(5): S1.
  93. Yu JS, Ho CH, Hsu YC, Wang JJ, Hsieh CL. Traditional Chinese medicine treatments for upper respiratory tract infections/common colds in Taiwan. Eur J Integr Med 2014; 6(5): 538-44. doi: 10.1016/j.eujim.2014.06.003 PMID: 32288884
  94. Hu XY, Wu RH, Logue M, et al. Andrographis paniculata (ChuānXīn Lián) for symptomatic relief of acute respiratory tract infections in adults and children: A systematic review and meta-analysis. PLoS One 2017; 12(8): e0181780. doi: 10.1371/journal.pone.0181780 PMID: 28783743
  95. Hai-long Z, Shimin C, Yalan L. Some Chinese folk prescriptions for wind-cold type common cold. J Tradit Complement Med 2015; 5(3): 135-7. doi: 10.1016/j.jtcme.2014.11.035 PMID: 26151024
  96. Zheng N, Dai J, Cao H, et al. Current understanding on antihepatocarcinoma effects of Xiao Chai Hu Tang and its constituents. Evid Based Complement Alternat Med 2013; 2013: 1-14. doi: 10.1155/2013/529458 PMID: 23853661
  97. Li J, Zhang K, Bao J, Yang J, Wu C. Potential mechanism of action of Jing Fang Bai Du San in the treatment of COVID-19 using docking and network pharmacology. Int J Med Sci 2022; 19(2): 213-24. doi: 10.7150/ijms.67116 PMID: 35165507
  98. Kong DZ, Liang N, Yang GL, et al. Xiao Chai Hu Tang, a herbal medicine, for chronic hepatitis B. Cochrane Libr 2019; 2019(11): 1-83. doi: 10.1002/14651858.CD013090.pub2 PMID: 31697415
  99. Liu Y, Chen M, Guo Q, Li Y, Jiang J, Shi J. Aromatic compounds from an aqueous extract of "Ban Lan Gen" and their antiviral activities. Acta Pharm Sin B 2017; 7(2): 179-84. doi: 10.1016/j.apsb.2016.09.004 PMID: 28303224
  100. Xiao J, Wu J, Yu B. Therapeutic efficacy of Youdujing preparation in treating cervical high-risk human papilloma virus infection patients. Chin J Integr Med 2012; 32(9): 1212-5.
  101. Yarnell E. Herbs against human papillomavirus. Altern Complement Ther 2015; 21(2): 71-6. doi: 10.1089/act.2015.21205
  102. Liu T, Xin B, Zhang Q, et al. Exploring the molecular mechanism of Huangqin-Jinyinhua couplet medicines for the treatment of hand-foot and mouth disease using network pharmacology, molecular docking and bioinformatics databases. Intellig Pharm 2023; 1(2): 106-15. doi: 10.1016/j.ipha.2023.04.007
  103. Ali-Seyed M, Vijayaraghavan K. Dengue virus infections and anti-dengue virus activities of Andrographis paniculata. Asian Pac J Trop Med 2020; 13(2): 49-55. doi: 10.4103/1995-7645.275412
  104. Liu ZB, Yang JP, Xu LR. Effectiveness and safety of traditional Chinese medicine in treating acquired immune deficiency syndrome: 2004-2014. Infect Dis Poverty 2015; 4(1): 59. doi: 10.1186/s40249-015-0093-6 PMID: 26699285
  105. Zou W, Liu Y, Wang J, Li H, Liao X. Traditional Chinese herbal medicines for treating HIV infections and AIDS. Evid Based Complement Alternat Med 2012; 2012: 1-8. doi: 10.1155/2012/950757 PMID: 23326295
  106. Tahmasbi SF, Revell MA, Tahmasebi N. Herbal medication to enhance or modulate viral infections. Nurs Clin North Am 2021; 56(1): 79-89. doi: 10.1016/j.cnur.2020.10.007 PMID: 33549288
  107. Chime SA, Madumere CP. Herbal medicines as potential immune boosters against coronavirus diseases. Curr Tradit Med 2023; 9(2): e290322202751. doi: 10.2174/2215083808666220329122149
  108. Wang FC, Han P, Li H, et al. Advantages and prospects of traditional Chinese medicine in treating COVID-19. Trad Med Res 2023; 8(4): 22. doi: 10.53388/TMR20220809001
  109. Chen YH, Yin MQ, Fan LH, et al. Bibliometric analysis of traditional Chinese medicine research on heart failure in the 21st century based on the WOS database. Heliyon 2023; 9(1): e12770. doi: 10.1016/j.heliyon.2022.e12770 PMID: 36691539
  110. Zheng S, Yang L, Zhou P, Li H, Liu F, Zhao R. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective. Res Social Adm Pharm 2021; 17(1): 1819-24. doi: 10.1016/j.sapharm.2020.03.012 PMID: 32249102
  111. Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID-19: A randomised, double-blind, placebo-controlled, multicentre trial. Lancet 2020; 395(10236): 1569-78. doi: 10.1016/S0140-6736(20)31022-9 PMID: 32423584
  112. Jin D, Wang J, Xue J, et al. Contribution of Chinese herbal medicine in the treatment of coronavirus disease 2019 (COVID -19): A systematic review and meta-analysis of randomized controlled trials. Phytother Res 2023; 37(3): 1015-35. doi: 10.1002/ptr.7669 PMID: 36382689
  113. Guo YR, Cao QD, Hong ZS, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - An update on the status. Mil Med Res 2020; 7(1): 11. doi: 10.1186/s40779-020-00240-0 PMID: 31928528
  114. Semenova Y, Pivina L, Khismetova Z, et al. Anticipating the need for healthcare resources following the escalation of the COVID-19 outbreak in the Republic of Kazakhstan. J Prev Med Public Health 2020; 53(6): 387-96. doi: 10.3961/jpmph.20.395 PMID: 33296578
  115. Aliabadi AMH, Keihan ER, Parikhani BA, et al. COVID-19: A systematic review and update on prevention, diagnosis, and treatment. MedComm 2022; 3(1): e115. doi: 10.1002/mco2.115 PMID: 35281790
  116. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun 2020; 109: 102433. doi: 10.1016/j.jaut.2020.102433 PMID: 32113704
  117. Carlos WG, Dela Cruz CS, Cao B, Pasnick S, Jamil S. Novel Wuhan (2019-nCoV) coronavirus. Am J Respir Crit Care Med 2020; 201(4): 7-P8. doi: 10.1164/rccm.2014P7 PMID: 32004066
  118. Guo FL, Tao W,, Ming WX, Ping W. Discussion on etiology and pathogenesis of corona virus disease 2019 from "Cold-dampness and insidious dryness". Digit Chin Med 2020; 3(1): 50-4. doi: 10.1016/j.dcmed.2020.03.006
  119. Yan DX, Yu XP, Shi KH, Song WB, Zhang HY, Wei JL. Discussion about treatment of severe acute respiratory syndrome based on syndrome differentiation. J Chin Integr Med 2004; 2(4): 241-4. doi: 10.3736/jcim20040401 PMID: 15339403
  120. Li M, Yang X, Li K, Xie Y. Traditional Chinese medicine for novel coronavirus pneumonia treatment: Main force or supplement? Trad Med Res 2020; 5(2): 62-4. doi: 10.53388/TMR20200204158
  121. Zhao M, Chen Y, Wang C, et al. Systems pharmacology dissection of multi-scale mechanisms of action of Huo-Xiang-Zheng-Qi formula for the treatment of gastrointestinal diseases. Front Pharmacol 2019; 9: 1448. doi: 10.3389/fphar.2018.01448 PMID: 30687082
  122. Cui H, Li Y, Guo L, et al. Traditional Chinese medicine for treatment of coronavirus disease 2019: A review. Trad Med Res 2020; 5(2): 65-73. doi: 10.53388/TMR20200222165
  123. Zhu Y, Han Q, Wang L, et al. Jinhua Qinggan granules attenuates acute lung injury by promotion of neutrophil apoptosis and inhibition of TLR4/MyD88/NF-κB pathway. J Ethnopharmacol 2023; 301: 115763. doi: 10.1016/j.jep.2022.115763 PMID: 36183949
  124. Tao Z, Yang Y, Shi W, et al. Complementary and alternative medicine is expected to make greater contribution in controlling the prevalence of influenza. Biosci Trends 2013; 7(5): 253-6. doi: 10.5582/bst.2013.v7.5.253 PMID: 24241177
  125. Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 2020; 368: m606. doi: 10.1136/bmj.m606 PMID: 32075786
  126. Wang Z, Yang L. Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts. J Ethnopharmacol 2021; 270: 113869. doi: 10.1016/j.jep.2021.113869 PMID: 33485973
  127. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020; 46(5): 846-8. doi: 10.1007/s00134-020-05991-x PMID: 32125452
  128. Ji S, Bai Q, Wu X, et al. Unique synergistic antiviral effects of Shufeng Jiedu capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease. Biomed Pharmacother 2020; 121: 109652. doi: 10.1016/j.biopha.2019.109652 PMID: 31734578
  129. Lin Y, Yang X, Lu M, et al. Herbal compound triptolide synergistically enhanced antitumor activity of vasostatin120-180. Anticancer Drugs 2013; 24(9): 945-57. doi: 10.1097/CAD.0b013e3283651862 PMID: 23958791
  130. Cheng L, Li F, Ma R, Hu X. Forsythiaside inhibits cigarette smoke-induced lung inflammation by activation of Nrf2 and inhibition of NF-κB. Int Immunopharmacol 2015; 28(1): 494-9. doi: 10.1016/j.intimp.2015.07.011 PMID: 26209933
  131. Xi Z, Zhou J, Mei J, et al. Effect of Shufeng Jiedu capsule on the fever caused by viral upper respiratory tract infection: A report of 130 cases. J Tradit Chin Med 2010; 51: 426-7.
  132. Lv W, Zhu T, Qiu H, Hu T, Huang S. Pharmacodynamic study on antiviral and antibacterial effects of Shufeng Jiedu capsules in vitro. Trad Chin Drug Res Clin Pharma 2013; 3: 234-8.
  133. Li Y, Chang N, Han Y, et al. Anti-inflammatory effects of Shufeng Jiedu capsule for upper respiratory infection via the ERK pathway. Biomed Pharmacother 2017; 94: 758-66. doi: 10.1016/j.biopha.2017.07.118 PMID: 28802227
  134. Tao Z, Meng X, Han Y, et al. Therapeutic mechanistic studies of Shufeng Jiedu capsule in an acute lung injury animal model using quantitative proteomics technology. J Proteome Res 2017; 16(11): 4009-19. doi: 10.1021/acs.jproteome.7b00409 PMID: 28880561
  135. Tao Z, Gao J, Zhang G, et al. Shufeng Jiedu capsule protect against acute lung injury by suppressing the mAPK/NF-κB pathway. Biosci Trends 2014; 8(1): 45-51. doi: 10.5582/bst.8.45 PMID: 24647112
  136. Yuan Y, Liao Q, Xue M, et al. Shufeng Jiedu capsules alleviate lipopolysaccharide-induced acute lung inflammatory injury via activation of GPR18 by verbenalin. Cell Physiol Biochem 2018; 50(2): 629-39. doi: 10.1159/000494184 PMID: 30308517
  137. Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends 2020; 14(1): 69-71. doi: 10.5582/bst.2020.01020 PMID: 31996494
  138. Lin S, Wang X, Guo H, et al. The ethanol extract of evodiae fructus and its ingredient, rutaecarpine, inhibit infection of SARS-CoV-2 and inflammatory responses. Int J Mol Sci 2023; 24(1): 762. doi: 10.3390/ijms24010762 PMID: 36614206
  139. Lee DYW, Li QY, Liu J, Efferth T. Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis. Phytomedicine 2021; 80: 153337. doi: 10.1016/j.phymed.2020.153337 PMID: 33221457
  140. Zhang D, Zhang X, Peng B, et al. Network pharmacology suggests biochemical rationale for treating COVID-19 symptoms with a traditional Chinese medicine. Commun Biol 2020; 3(1): 466. doi: 10.1038/s42003-020-01190-y PMID: 32811894
  141. Bai Y, Yao L, Wei T, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA 2020; 323(14): 1406-7. doi: 10.1001/jama.2020.2565 PMID: 32083643
  142. Chan JFW, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet 2020; 395(10223): 514-23. doi: 10.1016/S0140-6736(20)30154-9 PMID: 31986261
  143. Han L, Wei XX, Zheng YJ, et al. Potential mechanism prediction of Cold-Damp Plague Formula against COVID-19 via network pharmacology analysis and molecular docking. Chin Med 2020; 15(1): 78. doi: 10.1186/s13020-020-00360-8 PMID: 32754224
  144. Nishi A, Kaifuchi N, Shimobori C, et al. Effects of maoto (Ma-huang-Tang) on host lipid mediator and transcriptome signature in influenza virus infection. Sci Rep 2021; 11(1): 4232. doi: 10.1038/s41598-021-82707-1 PMID: 33608574
  145. Ang L, Lee HW, Choi JY, Zhang J, Lee MS. Herbal medicine and pattern identification for treating COVID-19: A rapid review of guidelines. Integr Med Res 2020; 9(2): 100407. doi: 10.1016/j.imr.2020.100407 PMID: 32289016
  146. Liu J, Manheimer E, Shi Y, Gluud C. Chinese herbal medicine for severe acute respiratory syndrome: A systematic review and meta-analysis. J Altern Complement Med 2004; 10(6): 1041-51. doi: 10.1089/acm.2004.10.1041 PMID: 15674000
  147. Li Y, Liu X, Guo L, et al. Traditional Chinese herbal medicine for treating novel coronavirus (COVID-19) pneumonia: Protocol for a systematic review and meta-analysis. Syst Rev 2020; 9(1): 75. doi: 10.1186/s13643-020-01343-4 PMID: 32268923
  148. Zhang B, Qi F. Herbal medicines exhibit a high affinity for ACE2 in treating COVID-19. Biosci Trends 2023; 17(1): 14-20. doi: 10.5582/bst.2022.01534 PMID: 36596560
  149. Hempen C-H, Fischer T. A materia medica for Chinese medicine: plants, minerals, and animal products. Elsevier Health Sciences 2009.
  150. Luo H, Tang Q, Shang Y, et al. Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs. Chin J Integr Med 2020; 26(4): 243-50. doi: 10.1007/s11655-020-3192-6 PMID: 32065348
  151. Liu X, Zhang M, He L, Li Y. Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS). Cochrane Libr 2012; 10(10): CD004882. doi: 10.1002/14651858.CD004882.pub3 PMID: 23076910
  152. Chen XY, Wu TX, Liu GJ, et al. Chinese medicinal herbs for influenza. Cochrane Database Syst Rev 2007; 2007(4): CD004559. PMID: 17943819
  153. Yang Y, Islam MS, Wang J, Li Y, Chen X. Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): A review and perspective. Int J Biol Sci 2020; 16(10): 1708-17. doi: 10.7150/ijbs.45538 PMID: 32226288
  154. Zhang S, Yan X, Gao P, et al. Analysis of traditional Chinese medicine syndromes in patients with coronavirus disease 2019 in plateau areas. Chin Crit Care Med 2022; 34(12): 1330-2. PMID: 36567593
  155. Wang S, Wang Y, Lu Y, et al. Diagnosis and treatment of novel coronavirus pneumonia based on the theory of traditional Chinese medicine. J Integr Med 2020; 18(4): 275-83. doi: 10.1016/j.joim.2020.04.001 PMID: 32446813
  156. Tilburt J, Kaptchuk TJ. Herbal medicine research and global health: An ethical analysis. Bull World Health Organ 2008; 86(8): 594-9. doi: 10.2471/BLT.07.042820 PMID: 18797616
  157. Wang ZF, Wang YP, Zhang HM, Fan YP, Lü C, Wang YY. Thinking on clinical rational use of TCM injection in the treatment of novel coronavirus pneumonia (COVID-19). Chin Med J 2020; 100(14): 1044-7. PMID: 32294864
  158. Wang Z, Li L, Song M, Yan J, Shi J, Yao Y. Evaluating the traditional Chinese medicine (TCM) officially recommended in China for COVID-19 using ontology-based side-effect prediction framework (OSPF) and deep learning. J Ethnopharmacol 2021; 272: 113957. doi: 10.1016/j.jep.2021.113957 PMID: 33631276
  159. Zhang J, Dong X, Cao Y, et al. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy 2020; 75(7): 1730-41. doi: 10.1111/all.14238 PMID: 32077115
  160. Chan KW, Wong VT, Tang SCW. COVID-19: An update on the epidemiological, clinical, preventive and therapeutic evidence and guidelines of integrative Chinese-Western medicine for the management of 2019 novel coronavirus disease. Am J Chin Med 2020; 48(3): 737-62. doi: 10.1142/S0192415X20500378 PMID: 32164424
  161. Chen H, Du Q. Potential natural compounds for preventing 2019-nCoV infection. Preprints 2020; 2020010358.
  162. Yang L, Li Y, Miao J, et al. Network pharmacology studies on the effect of Chai-Ling decoction in coronavirus disease 2019. Trad Med Res 2020; 5(3): 145-59. doi: 10.53388/TMR20200324170
  163. Xiao G, Song K, Yuan C. A literature report on the treatment of SARS by stages with traditional Chinese medicine. J Emerg Chin Med Hunan 2005; 2005: 53-5.
  164. Bao L, Ma J. Research progress of Da Yuan Yin on the treatment of infectious diseases. J Emerg Tradit Chin Med 2010; 2: 263-87.
  165. Sun S, Shi Y, Yan H, et al. Xiyanping injection in treatment of viral pneumonia in children: A meta-analysis of random control trials. Chin Herb Med 2015; 7(2): 173-8. doi: 10.1016/S1674-6384(15)60035-1
  166. Song Y, Yao C, Yao Y, et al. XueBiJing injection versus placebo for critically ill patients with severe community-acquired pneumonia: A randomized controlled trial. Crit Care Med 2019; 47(9): e735-43. doi: 10.1097/CCM.0000000000003842 PMID: 31162191
  167. Liu W, Jiang H, Cai L, Yan M, Dong S, Mao B. Tanreqing injection attenuates lipopolysaccharide-induced airway inflammation through MAPK/NF-κB signaling pathways in rats model. Evid Based Complement Alternat Med 2016; 2016: 1-15. doi: 10.1155/2016/5292346
  168. Zhang YM, Qu XY, Zhai JH, et al. Xingnaojing injection protects against cerebral ischemia reperfusion injury via PI3K/Akt-mediated eNOS phosphorylation. Evid Based Complement Alternat Med 2018; 2018: 1-13. doi: 10.1155/2018/2361046 PMID: 30158991
  169. Liang X, Zhou M, Ge X-Y, et al. Efficacy of traditional Chinese medicine on sepsis: A systematic review and meta-analysis. Int J Clin Exp Med 2015; 8(11): 20024-34. PMID: 26884914
  170. Zong Y, Ding ML, Jia KK, Ma ST, Ju WZ. Exploring active compounds of Da-Yuan-Yin in treatment of COVID-19 based on network pharmacology and molecular docking method. Chin Tradit Herbal Drugs 2020; 51(4): 836-44.
  171. Wang Z, Chen X, Lu Y, Chen F, Zhang W. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci Trends 2020; 14(1): 64-8. doi: 10.5582/bst.2020.01030 PMID: 32037389
  172. Wu J, Cheng Z, He S, et al. Pinelliae rhizoma, a toxic chinese herb, can significantly inhibit CYP3A activity in rats. Molecules 2015; 20(1): 792-806. doi: 10.3390/molecules20010792 PMID: 25574821
  173. Xu J, Zhang Y. Traditional Chinese medicine treatment of COVID-19. Complement Ther Clin Pract 2020; 39: 101165. doi: 10.1016/j.ctcp.2020.101165 PMID: 32379692
  174. He JY, Ma N, Zhu S, Komatsu K, Li ZY, Fu WM. The genus Codonopsis (Campanulaceae): A review of phytochemistry, bioactivity and quality control. J Nat Med 2015; 69(1): 1-21. doi: 10.1007/s11418-014-0861-9 PMID: 25099952
  175. Zhao X, Dai X, Wang S, et al. Traditional Chinese medicine integrated with chemotherapy for stage II-IIIA patients with non-small-cell lung cancer after radical surgery: A retrospective clinical analysis with small sample size. Evid Based Complement Alternat Med 2018; 2018: 1-7. doi: 10.1155/2018/4369027 PMID: 30147731
  176. Chen X, Nie H, Liu W, et al. Efficacy and safety of Hou Gu Mi Xi on spleen qi deficiency in patients with nonorganic gastrointestinal disorders: Protocol for a multicenter, randomized, placebo-controlled trial. Evid Based Complement Alternat Med 2018; 2018: 1-8. doi: 10.1155/2018/1980491 PMID: 30622590
  177. Wu T, Yang X, Zeng X, Poole P. Traditional Chinese medicine in the treatment of acute respiratory tract infections. Respir Med 2008; 102(8): 1093-8. doi: 10.1016/j.rmed.2008.03.015 PMID: 18590956
  178. Yarnell E. Herbs for viral respiratory infections. Altern Complement Ther 2018; 24(1): 35-43. doi: 10.1089/act.2017.29150.eya
  179. Szopa A, Ekiert R, Ekiert H. Current knowledge of Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine) as a medicinal plant species: A review on the bioactive components, pharmacological properties, analytical and biotechnological studies. Phytochem Rev 2017; 16(2): 195-218. doi: 10.1007/s11101-016-9470-4 PMID: 28424569
  180. Luo L, Jiang J, Wang C, et al. Analysis on herbal medicines utilized for treatment of COVID-19. Acta Pharm Sin B 2020; 10(7): 1192-204. doi: 10.1016/j.apsb.2020.05.007 PMID: 32834949
  181. Bensky D, Clavey S, Stoger E, Gamble A. Chinese herbal medicine. In: Materia medica 3rd ed. Seattle, WA, USA: Eastland Press 2004.
  182. Badanta B, García MA, Jiménez ÁE, Lucchetti G, de Cordero DR. The use of complementary and traditional medicine for the treatment of patients with COVID-19: A systematic review. Explore (NY) 2023; 19(5): 646-62. doi: 10.1016/j.explore.2023.02.005 PMID: 36828766
  183. Yang Z, Liu Y, Wang L, et al. Traditional Chinese medicine against COVID-19: Role of the gut microbiota. Biomed Pharmacother 2022; 149: 112787. doi: 10.1016/j.biopha.2022.112787 PMID: 35279010
  184. He W, Shi X-S, Zhang Z-Y, et al. Discussion on the effect pathways of preventing and treating coronavirus disease 2019 by acupuncture and moxibustion from the regulation of immune inflammatory response. Chin Acupunct 2020; 40(8): 799-802. PMID: 32869585
  185. Gómez GO, Carralero WJ. Traditional Chinese medicine in the treatment of COVID-19. Int J Acupunct 2020; 14(3): 123-4. doi: 10.1016/j.acu.2020.07.001
  186. Ni L, Wen Z, Hu X, et al. Effects of Shuanghuanglian oral liquids on patients with COVID-19: A randomized, open-label, parallel-controlled, multicenter clinical trial. Front Med 2021; 15(5): 704-17. doi: 10.1007/s11684-021-0853-6 PMID: 33909260
  187. Zeng C, Yuan Z, Zhu J, et al. Therapeutic effects of traditional Chinese medicine (Maxingshigan-Weijing decoction) on COVID-19: An open-label randomized controlled trial. Integr Med Res 2021; 10: 100782. doi: 10.1016/j.imr.2021.100782 PMID: 34660195
  188. Zhang XY, Lv L, Zhou YL, et al. Efficacy and safety of Xiyanping injection in the treatment of COVID-19: A multicenter, prospective, open-label and randomized controlled trial. Phytother Res 2021; 35(8): 4401-10. doi: 10.1002/ptr.7141 PMID: 33979464
  189. Su YC, Huang GJ, Lin JG. Chinese herbal prescriptions for COVID-19 management: Special reference to Taiwan Chingguan Yihau (NRICM101). Front Pharmacol 2022; 13: 928106. doi: 10.3389/fphar.2022.928106 PMID: 36278162
  190. Kang X, Jin D, Jiang L, et al. Efficacy and mechanisms of traditional Chinese medicine for COVID-19: A systematic review. Chin Med 2022; 17(1): 30. doi: 10.1186/s13020-022-00587-7 PMID: 35227280
  191. Shah T, Xia KY, Shah Z, Baloch Z. Therapeutic mechanisms and impact of traditional Chinese medicine on COVID-19 and other influenza diseases. Pharmacol Res - Mod Chin Med. 2022; 2: 100029. doi: 10.1016/j.prmcm.2021.100029

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers